Data gathered: February 23
AI Stock Analysis - Bristol-Myers Squibb (BMY)
Analysis generated November 29, 2024. Powered by Chat GPT.
Bristol Myers Squibb (BMY) is a globally recognized biopharmaceutical company. It focuses on discovering, developing, and delivering innovative medicines that help patients overcome serious diseases. The company is known for its robust pipeline of potential products and a strong portfolio of existing therapies catering to oncology, cardiovascular, immunoscience, and fibrotic diseases.
Stock Alerts - Bristol-Myers Squibb (BMY)
 |
Bristol-Myers Squibb | February 22 Insider Alert: BOERNER CHRISTOPHER S. is buying shares |
|
Bristol-Myers Squibb | February 20 Insider Alert: Hirawat Samit is buying shares |
|
Bristol-Myers Squibb | February 13 Julie Johnson (member of U.S. congress) is buying shares |
|
Bristol-Myers Squibb | February 11 Employee Rating is down by 2.6% over the last month. |
Alternative Data for Bristol-Myers Squibb
About Bristol-Myers Squibb
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
| Price | $55.83 |
| Target Price | Sign up |
| Volume | 11,100,000 |
| Market Cap | $113B |
| Year Range | $38.61 - $60.6 |
| Dividend Yield | 4.44% |
| PE Ratio | 12.66 |
| Analyst Rating | 33% buy |
| Industry | Drug Manufacturers |
In the news
 |
Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology SuccessFebruary 20 - SeekingAlpha |
 |
Nations Financial Group Inc. IA ADV Sells 708 Shares of Bristol-Myers Squibb (NYSE:BMY)February 19 - ETF Daily News |
 |
Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy NowFebruary 16 - Yahoo Entertainment |
|
Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”February 12 - Yahoo Entertainment |
|
Research Analysts Set Expectations for BMY Q2 EarningsFebruary 12 - ETF Daily News |
 |
Wells Fargo & Company Increases Bristol-Myers Squibb (NYSE:BMY) Price Target to $62.00February 10 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 12.3B | 8.73B | 3.62B | 72M | -1.84B | 1.670 |
| Q3 '24 | 11.9B | 7.5B | 4.39B | 1.21B | -129M | 1.800 |
| Q2 '24 | 12.2B | 7.67B | 4.53B | 1.68B | -438M | 2.070 |
| Q1 '24 | 11.9B | 7.77B | 4.09B | -11.9B | -8.69B | -4.400 |
| Q4 '23 | 11.5B | 7.19B | 4.29B | 1.76B | 4.29B | 1.590 |
Insider Transactions View All
| BOERNER CHRISTOPHER S. filed to buy 104,626 shares at $55. February 21 '25 |
| Hirawat Samit filed to buy 63,932 shares at $54.8. February 19 '25 |
| Holzer Phil M filed to sell 11,760 shares at $55.6. November 5 '24 |
| Hirawat Samit filed to buy 62,109 shares at $54.7. November 5 '24 |
| BOERNER CHRISTOPHER S. filed to buy 82,672 shares at $49.8. December 7 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$162.3 0% | 63 |
 |
Eli Lilly and CompanyLLY |
$873.68 0% | 58 |
 |
PfizerPFE |
$26.3 0% | 52 |
 |
AstrazenecaAZN |
$74.22 0% | 52 |
 |
AbbVieABBV |
$202.08 0% | 59 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson |
Feb 13, 25 | Buy | $1K - $15K |
| Virginia Foxx |
Jan 7, 25 | Buy | $1K - $15K |
| John James |
Sep 2, 24 | Buy | $1K - $15K |
Read more about Bristol-Myers Squibb (BMY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Bristol-Myers Squibb?
The Market Cap of Bristol-Myers Squibb is $113B.
What is Bristol-Myers Squibb's PE Ratio?
As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 12.66.
What is the current stock price of Bristol-Myers Squibb?
Currently, the price of one share of Bristol-Myers Squibb stock is $55.83.
How can I analyze the BMY stock price chart for investment decisions?
The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.
Does BMY offer dividends to its shareholders?
Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 4.44%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Bristol-Myers Squibb?
Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.